$504 Million is the total value of VHCP Management III, LLC's 18 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 450.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CNST | Buy | Constellation Pharmaceuticals | $118,540,000 | +27403.5% | 2,516,242 | +3674.3% | 23.54% | +8748.5% |
RLMD | New | Relmada Therapeutics Inc | $29,950,000 | – | 767,938 | +100.0% | 5.95% | – |
ETNB | New | 89Bio Inc | $25,206,000 | – | 958,765 | +100.0% | 5.00% | – |
FTSV | New | Forty Seven Inc | $20,330,000 | – | 516,381 | +100.0% | 4.04% | – |
ITCI | New | Intra-Cellular Therapies Inc | $19,728,000 | – | 575,000 | +100.0% | 3.92% | – |
ISEE | New | Iveric Bio Inc | $14,584,000 | – | 1,699,797 | +100.0% | 2.90% | – |
ADVM | New | Adverum Biotechnologies Inc | $10,901,000 | – | 946,234 | +100.0% | 2.16% | – |
MRNS | Buy | Marinus Pharmaceuticals Inc | $10,835,000 | +179.6% | 5,016,164 | +99.4% | 2.15% | -10.1% |
MRSN | New | Mersana Therapeutics Inc | $8,947,000 | – | 1,561,389 | +100.0% | 1.78% | – |
MYOV | New | Myovant Sciences Ltd | $7,066,000 | – | 455,255 | +100.0% | 1.40% | – |
NXTC | New | Nextcure Inc | $6,742,000 | – | 119,693 | +100.0% | 1.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Kalvista Pharmaceuticals | 6 | Q4 2019 | 21.5% |
Obseva SA | 6 | Q4 2019 | 15.8% |
Constellation Pharmaceuticals | 6 | Q4 2019 | 23.5% |
Marinus Pharmaceuticals Inc | 6 | Q4 2019 | 5.1% |
Bellerophon Therapeutics | 6 | Q4 2019 | 1.9% |
BioCryst Pharmaceuticals Inc | 5 | Q3 2019 | 18.0% |
Tricida Inc | 5 | Q3 2019 | 15.0% |
Protagonist Therapeutics Inc | 5 | Q4 2019 | 8.0% |
Kiniksa Pharmaceuticals Ltd | 5 | Q3 2019 | 6.7% |
Axsome Therapeutics Inc | 4 | Q4 2019 | 31.8% |
View VHCP Management III, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2024-02-22 |
4 | 2024-02-08 |
4 | 2024-02-01 |
4 | 2024-01-29 |
4 | 2024-01-24 |
4 | 2024-01-19 |
4 | 2024-01-16 |
4 | 2024-01-10 |
4 | 2024-01-05 |
4 | 2023-12-29 |
View VHCP Management III, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.